FDA Leadership Changes Trigger Fresh Concerns Over U.S. Drug Oversight and Approvals Washington 2026
WASHINGTON, D.C., United States – May 15, 2026 – Brussels Morning Newspaper — FDA leadership changes are creating growing uncertainty across the American healthcare and pharmaceutical industries after reports suggested that another senior agency official could soon depart following recent executive transitions inside the Food and Drug Administration. The latest developments are intensifying concerns about long-term regulatory […]
